ID   UBP8_YEAST              Reviewed;         471 AA.
AC   P50102; D6W048;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   07-APR-2021, entry version 188.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 8;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 8;
DE   AltName: Full=Ubiquitin thioesterase 8;
DE   AltName: Full=Ubiquitin-specific-processing protease 8;
GN   Name=UBP8; OrderedLocusNames=YMR223W; ORFNames=YM9959.05;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S., Jagels K.,
RA   Lye G., Moule S., Odell C., Pearson D., Rajandream M.A., Rice P.,
RA   Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII.";
RL   Nature 387:90-93(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   FUNCTION IN HISTONE ACETYLATION AT THE SAGA COMPLEX.
RX   PubMed=10026213; DOI=10.1074/jbc.274.9.5895;
RA   Grant P.A., Eberharter A., John S., Cook R.G., Turner B.M., Workman J.L.;
RT   "Expanded lysine acetylation specificity of Gcn5 in native complexes.";
RL   J. Biol. Chem. 274:5895-5900(1999).
RN   [4]
RP   IDENTIFICATION IN THE SLIK COMPLEX.
RX   PubMed=12446794; DOI=10.1128/mcb.22.24.8774-8786.2002;
RA   Pray-Grant M.G., Schieltz D., McMahon S.J., Wood J.M., Kennedy E.L.,
RA   Cook R.G., Workman J.L., Yates J.R. III, Grant P.A.;
RT   "The novel SLIK histone acetyltransferase complex functions in the yeast
RT   retrograde response pathway.";
RL   Mol. Cell. Biol. 22:8774-8786(2002).
RN   [5]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [6]
RP   FUNCTION IN HISTONE DEUBIQUITINATION ACTIVITY OF THE SAGA COMPLEX,
RP   IDENTIFICATION IN THE SAGA COMPLEX, AND IDENTIFICATION IN THE SLIK COMPLEX.
RX   PubMed=14660634; DOI=10.1074/jbc.c300494200;
RA   Daniel J.A., Torok M.S., Sun Z.W., Schieltz D., Allis C.D., Yates J.R. III,
RA   Grant P.A.;
RT   "Deubiquitination of histone H2B by a yeast acetyltransferase complex
RT   regulates transcription.";
RL   J. Biol. Chem. 279:1867-1871(2004).
RN   [7]
RP   FUNCTION IN HISTONE DEUBIQUITINATION ACTIVITY OF THE SAGA COMPLEX,
RP   IDENTIFICATION IN THE SAGA COMPLEX, INTERACTION WITH SGF11, AND MUTAGENESIS
RP   OF CYS-46; CYS-49; HIS-77; CYS-146 AND HIS-419.
RX   PubMed=15657441; DOI=10.1128/mcb.25.3.1162-1172.2005;
RA   Ingvarsdottir K., Krogan N.J., Emre N.C.T., Wyce A., Thompson N.J.,
RA   Emili A., Hughes T.R., Greenblatt J.F., Berger S.L.;
RT   "H2B ubiquitin protease Ubp8 and Sgf11 constitute a discrete functional
RT   module within the Saccharomyces cerevisiae SAGA complex.";
RL   Mol. Cell. Biol. 25:1162-1172(2005).
RN   [8]
RP   IDENTIFICATION IN THE SLIK COMPLEX.
RX   PubMed=15647753; DOI=10.1038/nature03242;
RA   Pray-Grant M.G., Daniel J.A., Schieltz D., Yates J.R. III, Grant P.A.;
RT   "Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-
RT   dependent acetylation.";
RL   Nature 433:434-438(2005).
CC   -!- FUNCTION: Functions as histone deubiquitinating component of the
CC       transcription regulatory histone acetylation (HAT) complexes SAGA and
CC       SLIK. SAGA is involved in RNA polymerase II-dependent transcriptional
CC       regulation of approximately 10% of yeast genes. At the promoters, SAGA
CC       is required for recruitment of the basal transcription machinery. It
CC       influences RNA polymerase II transcriptional activity through different
CC       activities such as TBP interaction (SPT3, SPT8 and SPT20) and promoter
CC       selectivity, interaction with transcription activators (GCN5, ADA2,
CC       ADA3 and TRA1), and chromatin modification through histone acetylation
CC       (GCN5) and deubiquitination (UBP8). SAGA acetylates nucleosomal histone
CC       H3 to some extent (to form H3K9ac, H3K14ac, H3K18ac and H3K23ac). SAGA
CC       interacts with DNA via upstream activating sequences (UASs). SLIK is
CC       proposed to have partly overlapping functions with SAGA. It
CC       preferentially acetylates methylated histone H3, at least after
CC       activation at the GAL1-10 locus. Together with SGF11, is required for
CC       histone H2B deubiquitination. {ECO:0000269|PubMed:10026213,
CC       ECO:0000269|PubMed:14660634, ECO:0000269|PubMed:15657441}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12;
CC   -!- SUBUNIT: Component of the 1.8 MDa SAGA complex, which consists of at
CC       least of TRA1, CHD1, SPT7, TAF5, ADA3, SGF73, SPT20/ADA5, SPT8, TAF12,
CC       TAF6, HFI1/ADA1, UBP8, GCN5, ADA2, SPT3, SGF29, TAF10, TAF9, SGF11 and
CC       SUS1. TAF5, TAF6, TAF9, TAF19, TAF12 and ADA1 seem to be present in 2
CC       copies. SAGA is built of 5 distinct domains with specialized functions.
CC       Domain I (containing TRA1) probably represents the activator
CC       interaction surface. Domain II (containing TAF5 and TAF6, and probably
CC       TAF9 and TAF10), domain III (containing GCN5, TAF10, SPT7, TAF5 and
CC       ADA1, and probably ADA2, ADA3 and TAF12), and domain IV (containing
CC       HFI1/ADA1 and TAF6, and probably TAF9) are believed to play primarily
CC       an architectural role. Domain III also harbors the HAT activity. Domain
CC       V (containing SPT3 and SPT20, and probably SPT8) represents the TBP-
CC       interacting module, which may be associated transiently with SAGA. UBP8
CC       interacts with SGF11. Component of the SLIK complex, which consists of
CC       at least TRA1, CHD1, SPT7, TAF5, ADA3, SPT20, RTG2, TAF12, TAF6, HFI1,
CC       UBP8, GCN5, ADA2, SPT3, TAF10 and TAF9. {ECO:0000269|PubMed:12446794,
CC       ECO:0000269|PubMed:14660634, ECO:0000269|PubMed:15647753,
CC       ECO:0000269|PubMed:15657441}.
CC   -!- INTERACTION:
CC       P50102; Q12060: HFI1; NbExp=9; IntAct=EBI-19863, EBI-8287;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- DOMAIN: The UBP-type zinc finger domain is required for the interaction
CC       with the SAGA complex.
CC   -!- MISCELLANEOUS: Present with 1030 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. UBP8 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z49939; CAA90194.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA10122.1; -; Genomic_DNA.
DR   PIR; S57591; S57591.
DR   RefSeq; NP_013950.1; NM_001182730.1.
DR   PDB; 3M99; X-ray; 2.70 A; A=1-471.
DR   PDB; 3MHH; X-ray; 2.45 A; A=1-471.
DR   PDB; 3MHS; X-ray; 1.89 A; A=1-471.
DR   PDB; 4FIP; X-ray; 2.69 A; A/E=1-471.
DR   PDB; 4FJC; X-ray; 2.83 A; A/E=1-471.
DR   PDB; 4FK5; X-ray; 2.03 A; A=1-471.
DR   PDB; 4WA6; X-ray; 2.36 A; A/D=1-471.
DR   PDB; 4ZUX; X-ray; 3.82 A; U/Z/e/j=1-471.
DR   PDB; 6AQR; X-ray; 2.10 A; A=1-471.
DR   PDB; 6T9L; EM; 3.60 A; K=1-471.
DR   PDBsum; 3M99; -.
DR   PDBsum; 3MHH; -.
DR   PDBsum; 3MHS; -.
DR   PDBsum; 4FIP; -.
DR   PDBsum; 4FJC; -.
DR   PDBsum; 4FK5; -.
DR   PDBsum; 4WA6; -.
DR   PDBsum; 4ZUX; -.
DR   PDBsum; 6AQR; -.
DR   PDBsum; 6T9L; -.
DR   SMR; P50102; -.
DR   BioGRID; 35401; 464.
DR   ComplexPortal; CPX-656; SAGA complex.
DR   ComplexPortal; CPX-675; SLIK (SAGA-like) complex.
DR   DIP; DIP-1506N; -.
DR   IntAct; P50102; 166.
DR   MINT; P50102; -.
DR   STRING; 4932.YMR223W; -.
DR   MEROPS; C19.087; -.
DR   MaxQB; P50102; -.
DR   PaxDb; P50102; -.
DR   PRIDE; P50102; -.
DR   EnsemblFungi; YMR223W_mRNA; YMR223W; YMR223W.
DR   GeneID; 855263; -.
DR   KEGG; sce:YMR223W; -.
DR   SGD; S000004836; UBP8.
DR   VEuPathDB; FungiDB:YMR223W; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   GeneTree; ENSGT00940000175497; -.
DR   HOGENOM; CLU_008279_11_2_1; -.
DR   InParanoid; P50102; -.
DR   OMA; FMSVILQ; -.
DR   EvolutionaryTrace; P50102; -.
DR   PRO; PR:P50102; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   RNAct; P50102; protein.
DR   GO; GO:0071819; C:DUBm complex; IDA:SGD.
DR   GO; GO:0000124; C:SAGA complex; IDA:SGD.
DR   GO; GO:0046695; C:SLIK (SAGA-like) complex; IDA:SGD.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:SGD.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IMP:SGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0016578; P:histone deubiquitination; IMP:SGD.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IMP:SGD.
DR   GO; GO:0034729; P:histone H3-K79 methylation; IMP:SGD.
DR   GO; GO:0008380; P:RNA splicing; IMP:SGD.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR037798; UBP8.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   PANTHER; PTHR21646:SF33; PTHR21646:SF33; 1.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   SMART; SM00290; ZnF_UBP; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Hydrolase; Metal-binding; Nucleus; Protease;
KW   Reference proteome; Thiol protease; Transcription;
KW   Transcription regulation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..471
FT                   /note="Ubiquitin carboxyl-terminal hydrolase 8"
FT                   /id="PRO_0000080593"
FT   DOMAIN          137..468
FT                   /note="USP"
FT   ZN_FING         44..105
FT                   /note="UBP-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00502"
FT   ACT_SITE        146
FT                   /note="Nucleophile"
FT   ACT_SITE        427
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10092,
FT                   ECO:0000255|PROSITE-ProRule:PRU10093"
FT   MUTAGEN         46
FT                   /note="C->A: Lowers histone H2B deubiquitination activity;
FT                   when associated with A-49."
FT                   /evidence="ECO:0000269|PubMed:15657441"
FT   MUTAGEN         49
FT                   /note="C->A: Lowers histone H2B deubiquitination activity;
FT                   when associated with A-46."
FT                   /evidence="ECO:0000269|PubMed:15657441"
FT   MUTAGEN         77
FT                   /note="H->A: Lowers histone H2B deubiquitination activity."
FT                   /evidence="ECO:0000269|PubMed:15657441"
FT   MUTAGEN         146
FT                   /note="C->S: Lowers histone H2B deubiquitination activity."
FT                   /evidence="ECO:0000269|PubMed:15657441"
FT   MUTAGEN         419
FT                   /note="H->A: Lowers histone H2B deubiquitination activity."
FT                   /evidence="ECO:0000269|PubMed:15657441"
FT   HELIX           5..10
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           14..32
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           36..43
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   TURN            47..49
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          54..64
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          66..68
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   TURN            69..72
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           73..81
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          85..88
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   TURN            89..91
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          94..96
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   TURN            97..100
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          101..103
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           107..110
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           112..117
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           118..124
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           130..132
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          142..144
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           146..156
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           159..166
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           169..173
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   TURN            179..181
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           183..195
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           214..226
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           228..230
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          231..234
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           238..256
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           260..267
FT                   /evidence="ECO:0007744|PDB:4FK5"
FT   HELIX           274..278
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          281..288
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   TURN            290..292
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          297..304
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          306..308
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           316..324
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          327..329
FT                   /evidence="ECO:0007744|PDB:4FJC"
FT   TURN            337..340
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          341..343
FT                   /evidence="ECO:0007744|PDB:4FJC"
FT   STRAND          346..354
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          356..362
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          365..367
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          369..371
FT                   /evidence="ECO:0007744|PDB:3M99"
FT   STRAND          373..375
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          384..387
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           389..391
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          409..422
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          425..433
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           435..437
FT                   /evidence="ECO:0007744|PDB:6AQR"
FT   STRAND          439..443
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          446..450
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   HELIX           452..455
FT                   /evidence="ECO:0007744|PDB:3MHS"
FT   STRAND          460..470
FT                   /evidence="ECO:0007744|PDB:3MHS"
SQ   SEQUENCE   471 AA;  53623 MW;  BC632F12FBD0F73C CRC64;
     MSICPHIQQV FQNEKSKDGV LKTCNAARYI LNHSVPKEKF LNTMKCGTCH EINSGATFMC
     LQCGFCGCWN HSHFLSHSKQ IGHIFGINSN NGLLFCFKCE DYIGNIDLIN DAILAKYWDD
     VCTKTMVPSM ERRDGLSGLI NMGSTCFMSS ILQCLIHNPY FIRHSMSQIH SNNCKVRSPD
     KCFSCALDKI VHELYGALNT KQASSSSTST NRQTGFIYLL TCAWKINQNL AGYSQQDAHE
     FWQFIINQIH QSYVLDLPNA KEVSRANNKQ CECIVHTVFE GSLESSIVCP GCQNNSKTTI
     DPFLDLSLDI KDKKKLYECL DSFHKKEQLK DFNYHCGECN STQDAIKQLG IHKLPSVLVL
     QLKRFEHLLN GSNRKLDDFI EFPTYLNMKN YCSTKEKDKH SENGKVPDII YELIGIVSHK
     GTVNEGHYIA FCKISGGQWF KFNDSMVSSI SQEEVLKEQA YLLFYTIRQV N
//
